The transcription factor SXR mediates drug, xenobiotic and steroid induction of a major drug–metabolizing enzyme. Drugs such as paclitaxel (Taxol) can bind and activate this transcription factor and therefore regulate their own metabolism and efflux from cells. Manipulation of this pathway might lead to new ways to improve therapeutic efficacy and to minimize toxicity (584–590).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma
BMC Gastroenterology Open Access 06 October 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Synold, T.W., Dussault, I. & Forman, B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nature Med. 7, 584–590 (2001).
Schuetz, E.G., Beck, W.T. & Schuetz, J.D. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49, 311–318 (1996).
Borcherding, S.M., Baciewicz, A.M. & Self, T.H. Update on rifampin drug interactions II. Arch. Intern. Med. 152, 711–716 (1992).
Relling, M.V. et al. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 356, 285–290 (2000).
Lehmann, J.M. et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1–8 (1998).
Blumberg, B. et al. SXR, a novel steroid and xenobiotic sensing nuclear receptor. Genes Dev. 12, 3195–3205 (1998).
Staudinger, J.L. et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc. Natl. Acad. Sci. USA 98, 3369–3374 (2001).
Schuetz, E.G., Brimer, C. & Schuetz, J.D. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone utilize the nuclear hormone receptor PXR to activate the cytochrome P4503A23 hormone response element. Mol. Pharmacol. 54, 1113–1117 (1998).
Moore, L.B. et al. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. USA 97, 7500–7502 (2000).
Kostrubsky, V.E. et al. The Use of Human Hepatocytes to Study Induction of Cytochrome P-450. Drug Metab. Dispos. 27, 887–894 (1999).
Sonnichsen, D.S. et al. Variability in human cytochrome P450 paclitaxel metabolism. J. Pharmacol. Exp. Ther. 275, 566–575 (1995).
Sparreboom, A. et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA 94, 2031–2035 (1997).
Wandel, C. et al. P-glycoprotein and cytochrome P-4503A Inhibition: dissociation of inhibitory potencies. Cancer Res. 59, 3944–3948 (1999).
Schuetz, E.G., Schinkel, A.H., Relling, M.V. & Schuetz, J.D. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc. Natl. Acad. Sci. USA 93, 4001–4005 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schuetz, E., Strom, S. Promiscuous regulator of xenobiotic removal. Nat Med 7, 536–537 (2001). https://doi.org/10.1038/87856
Issue Date:
DOI: https://doi.org/10.1038/87856
This article is cited by
-
Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma
BMC Gastroenterology (2011)
-
Elucidating the ‘Jekyll and Hyde’ Nature of PXR: The Case for Discovering Antagonists or Allosteric Antagonists
Pharmaceutical Research (2009)
-
Drug resistance in brain diseases and the role of drug efflux transporters
Nature Reviews Neuroscience (2005)